Botanix Pharmaceuticals Market capitalization 2024

The Botanix Pharmaceuticals Market capitalization history

YEAR	REVENUE (undefined AUD)	GROSS MARGIN (%)	NET INCOME (undefined AUD)
2026e	90.09	-2,18	47.73
2025e	30.81	-6,36	15.91
2024e	0.81	-242,57	-15.91
2023	0.17	-1160,52	-9.15
2022	0.04	-20176,61	-13.17
2021	0.1	308,31	-3.33
2020	0.17	-1149,02	-16.73
2019	0.19	-1006,11	-17.04
2018	0.23	-840,59	-11.01
2017	0.05	-4215,05	-4.77
2016	-	-	-1.71
2015	0.04	-4548,62	-1.01
2014	0.02	-9800,00	-1.13
2013	-	-	-1.85
2012	-	-	-1.57
2011	-	-	-1.52
2010	-	-	-3.95
2009	0.01	-19600,00	-3.04
2008	0.04	-4900,00	-2.83
2007	0.05	-3920,00	-3.42
2006	0.09	-2177,78	-2.78
2005	0.35	-560,00	-29.76
2004	2.19	-89,50	-0.96

Botanix Pharmaceuticals Aktienanalyse

What does Botanix Pharmaceuticals do?

Botanix Pharmaceuticals Ltd is an Australian company specializing in the research and development of innovative therapies based on synthetic cannabinoids. The company was founded in 2014 by a team of experts and is headquartered in Perth, Western Australia. The history of Botanix Pharmaceuticals began with the discovery of the medical properties of cannabinoids derived from the hemp plant. Cannabinoids have a wide therapeutic potential, ranging from pain and inflammation relief to the treatment of seizure disorders and anxiety. Botanix Pharmaceuticals utilizes these properties to develop innovative product candidates that have high efficacy and tolerability. The business model of Botanix Pharmaceuticals is based on the concept of targeted treatment for diseases and conditions where traditional therapies are insufficient or cause unwanted side effects. The company develops and produces medications based on synthetic cannabinoids that target specific disease states and indications. Botanix Pharmaceuticals specializes in two areas. Firstly, it focuses on the development of topical products, such as ointments and creams, that are applied to the skin. These products are particularly effective in treating skin conditions such as acne or psoriasis. Secondly, the company is working on the development of medications for the treatment of internal conditions such as epilepsy or chronic obstructive pulmonary disease (COPD). In the field of topical products, Botanix Pharmaceuticals has already achieved significant success. The company has a promising pipeline of product candidates for various applications, including acne, psoriasis, atopic dermatitis, and bacterial infections. One promising drug candidate is BTX 1503, which was developed for the treatment of severe acne. It contains the synthetic cannabinoid BTX 1308, which possesses anti-inflammatory and antimicrobial properties. BTX 1503 has already demonstrated high efficacy and tolerability in clinical studies. In the field of internal conditions, Botanix Pharmaceuticals collaborates closely with leading institutions and research facilities to develop innovative therapies for seizure disorders and COPD. One promising product candidate is BTX 1801, which was developed for the treatment of severe epilepsy. BTX 1801 contains the synthetic cannabinoid BTX 1204, which has shown high efficacy and tolerability in the treatment of seizures. Botanix Pharmaceuticals is an innovative company that develops highly effective and tolerable medications based on synthetic cannabinoids. The company has already achieved remarkable success in a short period and has established itself as a leading player in the industry. With its pipeline of promising product candidates and its close collaboration with renowned research institutions, Botanix Pharmaceuticals is well-positioned to develop further innovative therapies in the future. Botanix Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Botanix Pharmaceuticals's Market Capitalization

Botanix Pharmaceuticals's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Botanix Pharmaceuticals's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Botanix Pharmaceuticals's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Botanix Pharmaceuticals’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Botanix Pharmaceuticals stock

What is the current Botanix Pharmaceuticals market capitalization?

The current market capitalization of Botanix Pharmaceuticals is 386.57 M AUD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Botanix Pharmaceuticals.

How has the market capitalization of Botanix Pharmaceuticals developed in recent years?

The market capitalization of Botanix Pharmaceuticals has increased/decreased by 133.45% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Botanix Pharmaceuticals?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Botanix Pharmaceuticals?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Botanix Pharmaceuticals have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Botanix Pharmaceuticals pay?

Over the past 12 months, Botanix Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Botanix Pharmaceuticals is expected to pay a dividend of 0 AUD.

What is the dividend yield of Botanix Pharmaceuticals?

The current dividend yield of Botanix Pharmaceuticals is .

When does Botanix Pharmaceuticals pay dividends?

Botanix Pharmaceuticals pays a quarterly dividend. This is distributed in the months of April, October, April, November.

How secure is the dividend of Botanix Pharmaceuticals?

Botanix Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Botanix Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Botanix Pharmaceuticals located?

Botanix Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Botanix Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Botanix Pharmaceuticals from 10/25/1996 amounting to 0.048 AUD, you needed to have the stock in your portfolio before the ex-date on 10/3/1996.

When did Botanix Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/25/1996.

What was the dividend of Botanix Pharmaceuticals in the year 2023?

In the year 2023, Botanix Pharmaceuticals distributed 0 AUD as dividends.

In which currency does Botanix Pharmaceuticals pay out the dividend?

The dividends of Botanix Pharmaceuticals are distributed in AUD.